These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 34716900)

  • 1. Harnessing nanomedicine for enhanced immunotherapy for breast cancer brain metastases.
    Carney CP; Pandey N; Kapur A; Woodworth GF; Winkles JA; Kim AJ
    Drug Deliv Transl Res; 2021 Dec; 11(6):2344-2370. PubMed ID: 34716900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic Chemotherapy for Breast Cancer and Breast Cancer Brain Metastases via Paclitaxel-Loaded Oleanolic Acid Nanoparticles.
    Bao Y; Zhang S; Chen Z; Chen AT; Ma J; Deng G; Xu W; Zhou J; Yu ZQ; Yao G; Chen J
    Mol Pharm; 2020 Apr; 17(4):1343-1351. PubMed ID: 32150416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PSMA-targeted nanoparticles for specific penetration of blood-brain tumor barrier and combined therapy of brain metastases.
    Ni J; Miao T; Su M; Khan NU; Ju X; Chen H; Liu F; Han L
    J Control Release; 2021 Jan; 329():934-947. PubMed ID: 33069744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Checkpoint Inhibitors in the Treatment of Breast Cancer Brain Metastases.
    Schlam I; Gatti-Mays ME
    Oncologist; 2022 Jul; 27(7):538-547. PubMed ID: 35598254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting brain metastases in breast cancer.
    Corti C; Antonarelli G; Criscitiello C; Lin NU; Carey LA; Cortés J; Poortmans P; Curigliano G
    Cancer Treat Rev; 2022 Feb; 103():102324. PubMed ID: 34953200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-purposing the pro-senescence properties of doxorubicin to introduce immunotherapy in breast cancer brain metastasis.
    Uceda-Castro R; Margarido AS; Cornet L; Vegna S; Hahn K; Song JY; Putavet DA; van Geldorp M; Çitirikkaya CH; de Keizer PLJ; Ter Beek LC; Borst GR; Akkari L; van Tellingen O; Broekman MLD; Vennin C; van Rheenen J
    Cell Rep Med; 2022 Nov; 3(11):100821. PubMed ID: 36384097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining nanomedicine and immune checkpoint therapy for cancer immunotherapy.
    Boone CE; Wang L; Gautam A; Newton IG; Steinmetz NF
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jan; 14(1):e1739. PubMed ID: 34296535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Updates on the management of breast cancer brain metastases.
    Lim E; Lin NU
    Oncology (Williston Park); 2014 Jul; 28(7):572-8. PubMed ID: 25144276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of the immune microenvironment of primary breast cancer and brain metastasis reveals depleted T-cell response associated to ARG2 expression.
    Giannoudis A; Varešlija D; Sharma V; Zakaria R; Platt-Higgins A; Rudland PS; Jenkinson MD; Young LS; Palmieri C
    ESMO Open; 2022 Dec; 7(6):100636. PubMed ID: 36423363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining Nanomedicine and Immunotherapy.
    Shi Y; Lammers T
    Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mild hyperthermia promotes immune checkpoint blockade-based immunotherapy against metastatic pancreatic cancer using size-adjustable nanoparticles.
    Yu Q; Tang X; Zhao W; Qiu Y; He J; Wan D; Li J; Wang X; He X; Liu Y; Li M; Zhang Z; He Q
    Acta Biomater; 2021 Oct; 133():244-256. PubMed ID: 34000465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive genomic profiling to identify actionable alterations for breast cancer brain metastases in the Chinese population.
    Lu Q; Wang N; Jiang K; Zhou H; Zhang P; Zhang J; Wang S; Sun P; Xu F
    ESMO Open; 2024 Mar; 9(3):102389. PubMed ID: 38460250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are capecitabine and the active metabolite 5-Fu CNS penetrable to treat breast cancer brain metastasis?
    Zhang J; Zhang L; Yan Y; Li S; Xie L; Zhong W; Lv J; Zhang X; Bai Y; Cheng Z
    Drug Metab Dispos; 2015 Mar; 43(3):411-7. PubMed ID: 25547867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of prior systemic therapy on lymphocytic infiltration in surgically resected breast cancer brain metastases.
    Chew Minmin S; Bacotti A; Chen Y; Anders C; Sambade M; Deal AM; Trembath D; McKee MJ; Brogi E; Seidman AD
    Breast Cancer Res Treat; 2023 May; 199(1):99-107. PubMed ID: 36930347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autocatalytic Delivery of Brain Tumor-targeting, Size-shrinkable Nanoparticles for Treatment of Breast Cancer Brain Metastases.
    Zhang S; Deng G; Liu F; Peng B; Bao Y; Du F; Chen AT; Liu J; Chen Z; Ma J; Tang X; Chen Q; Zhou J
    Adv Funct Mater; 2020 Apr; 30(14):. PubMed ID: 32440263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive profiling of the immune microenvironment of breast cancer brain metastases.
    Griguolo G; Tosi A; Dieci MV; Fineberg S; Rossi V; Ventura A; Bottosso M; Bauchet L; Miglietta F; Jacob J; Rigau V; Fassan M; Jacot W; Conte P; Rosato A; Darlix A; Guarneri V
    Neuro Oncol; 2022 Dec; 24(12):2146-2158. PubMed ID: 35609559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanotechnology platforms for cancer immunotherapy.
    Yang Z; Ma Y; Zhao H; Yuan Y; Kim BYS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Mar; 12(2):e1590. PubMed ID: 31696664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic and Genomic Landscape of Breast Carcinoma Brain Metastases.
    Huang RSP; Haberberger J; McGregor K; Mata DA; Decker B; Hiemenz MC; Lechpammer M; Danziger N; Schiavone K; Creeden J; Graf RP; Strowd R; Lesser GJ; Razis ED; Bartsch R; Giannoudis A; Bhogal T; Lin NU; Pusztai L; Ross JS; Palmieri C; Ramkissoon SH
    Oncologist; 2021 Oct; 26(10):835-844. PubMed ID: 34105210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anti-tumor efficiency of low-dose apatinib-based chemotherapy in pretreated HER2-negative breast cancer with brain metastases.
    Chen X; Bai X; Xie X; Huang J; Chen L; Song L; Lan X; Zhang Q; Guo J; Du C
    Ann Med; 2023 Dec; 55(1):2218647. PubMed ID: 37260331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PI3K pathway inhibitors for the treatment of brain metastases with a focus on HER2+ breast cancer.
    Peddi PF; Hurvitz SA
    J Neurooncol; 2014 Mar; 117(1):7-13. PubMed ID: 24469856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.